Meet Axoltis Pharma at BIO 2026 Axoltis Pharma will be attending the BIO International Convention, one of the world’s leading biotechnology partnering events. 📅 June 22-25, 2026 📍 San Diego Convention Center Yann GODFRIN, Ph.D., CEO of Axoltis Pharma and Luca Bolliger, Chief Business Officer, will be on site and available for partnering discussions throughout the convention. We are proud to join the French delegation alongside more than 100 companies, with the support of Business France Healthcare - North America. Axoltis Pharma is a Phase 2 clinical-stage biotech advancing NX210c, under evaluation in a Phase 2 clinical trial in patients with ALS, with potential in Blood-Brain Barrier (BBB) integrity restoration, neuroprotection and neurotransmission. 👉 Let’s connect in San Diego and explore partnership opportunities #BIO2026 #Biotech #Pharma #ALS #ClinicalTrials #DrugDevelopment
Axoltis Pharma’s Post
Explore content categories
- Career
- Productivity
- Finance
- Soft Skills & Emotional Intelligence
- Project Management
- Education
- Technology
- Leadership
- Ecommerce
- User Experience
- Recruitment & HR
- Customer Experience
- Real Estate
- Marketing
- Sales
- Retail & Merchandising
- Science
- Supply Chain Management
- Future Of Work
- Consulting
- Writing
- Economics
- Artificial Intelligence
- Employee Experience
- Workplace Trends
- Fundraising
- Networking
- Corporate Social Responsibility
- Negotiation
- Communication
- Engineering
- Hospitality & Tourism
- Business Strategy
- Change Management
- Organizational Culture
- Design
- Innovation
- Event Planning
- Training & Development